EGFR‐mutant lung adenocarcinoma associated with antisynthetase syndrome successfully treated with osimertinib

Here, we report a rare case involving a 66‐year‐old man with epidermal growth factor receptor (EGFR)‐mutant lung adenocarcinoma and antisynthetase syndrome (ASS) treated with osimertinib. The patient presented with respiratory failure and bilateral pulmonary opacities; he was diagnosed with ASS acco...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Thorac Cancer
Главные авторы: Hara, Reina, Kanazu, Masaki, Iwai, Ami, Kuge, Tomoki, Ishijima, Mikako, Uenami, Takeshi, Akazawa, Yuki, Yano, Yukihiro, Yamaguchi, Toshihiko, Mori, Masahide
Формат: Artigo
Язык:Inglês
Опубликовано: John Wiley & Sons Australia, Ltd 2021
Предметы:
Case Reports
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC8088957/
https://ncbi.nlm.nih.gov/pubmed/33682361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13920
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы